Menu

MarketWise, Inc. MKTW

Full chart Compare
Set alert

Price alert · MKTW

All alert types
22.29 USD -0.09 (-0.40%)

At closeNov 10, 2026, 4:00 PM EST

22.29 0.00 0.00%

After hours · Nov 10, 4:00 PM ET

22.05 Day range 22.96
13.65 52-week range 22.38
YTD
+48.40%
1 year
+31.12%

Discussion (18)

Sign in to join the discussion

Wael Jawa MKTW 2 years ago #11

I have 40 k share should I sold it

Wael Jawa MKTW 2 years ago #14

Any idea here or should I sell my share here

Wael Jawa MKTW 2 years ago #16

I bought 16200 shares to see how this will go

VICKY HANUKA MKTW 3 years ago #18

Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi

-- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.